Domínguez Asenjo, B., Gutiérrez Corbo, M. d. C., Álvarez Bardón, M., Pérez Pertejo, M. Y., Balaña Fouce, R., & Reguera Torres, R. M. (2021). Ex vivo phenotypic screening of two small repurposing drug collections identifies nifuratel as a potential new treatment against visceral and cutaneous leishmaniasis.
Citación estilo ChicagoDomínguez Asenjo, Bárbara, María del Camino Gutiérrez Corbo, María Álvarez Bardón, Maria Yolanda Pérez Pertejo, Rafael Balaña Fouce, y Rosa María Reguera Torres. Ex Vivo Phenotypic Screening of Two Small Repurposing Drug Collections Identifies Nifuratel As a Potential New Treatment against Visceral and Cutaneous Leishmaniasis. 2021.
Cita MLADomínguez Asenjo, Bárbara, et al. Ex Vivo Phenotypic Screening of Two Small Repurposing Drug Collections Identifies Nifuratel As a Potential New Treatment against Visceral and Cutaneous Leishmaniasis. 2021.